BIOCARTIS

In News

Press Release Biocartis NV: Biocartis and Discovery Life - GlobeNewswire

GlobeNewswire - Jul 07, 2026

Press Release Biocartis NV: Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection of Pancreatic Cancer - Yahoo Finance

Yahoo Finance - Jun 09, 2026

Local Coverage Determinations Roundup: ChromaCode, Biofidelity, Biocartis, Bionano Genomics - GenomeWeb

GenomeWeb - Sep 10, 2026

Press Release Biocartis NV: Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures - The Manila Times

The Manila Times - Jan 12, 2026

DC Advisory advises Biocartis on enforcement by secured creditors and recapitalization of its main operating subsidiaries - DC Advisory

DC Advisory - Nov 16, 2023

Biocartis Introduces Influenza-Respiratory Virus Panel on Idylla Platform - respiratory-therapy.com

respiratory-therapy.com - Nov 09, 2023

Biocartis Launches qPCR POLE/POLD1 Mutational Assay - Oncology Nursing News

Oncology Nursing News - Apr 04, 2025

Biocartis grabs lab space, staff from Johnson & Johnson to fuel U.S. expansion - Fierce Biotech

Fierce Biotech - Mar 02, 2018

Biocartis Expands APIS Assay Technologies Collab to Commercialize Mutations Kit - Clinical Lab Products

Clinical Lab Products - Oct 12, 2023

Genomic Health and Biocartis Announce Agreement to Develop an Idylla™ IVD Oncotype DX® Breast Cancer Test to Broaden Global Patient Access - PR Newswire

PR Newswire - Sep 13, 2017

Idylla CDx MSI Test Earns FDA Approval in MSI-H Colorectal Cancer - CancerNetwork

CancerNetwork - Sep 16, 2025

FDA Grants Premarket Approval to Idylla CDx MSI Test for MSI-H CRC - OncLive

OncLive - Sep 15, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment